In addition to the main WHI studies, several ancillary studies have enrolled or are currently enrolling WHI participants. A few of the larger WHI ancillary studies are described below.
A clinical trial that will randomize approximately 22,000 men and women across the U.S. The study will investigate whether taking daily supplements of cocoa flavanols (600 mg/day) or a common multivitamin reduces the risk for developing heart disease, stroke, and cancer.
The WHI Life and Longevity After Cancer (LILAC) Study was funded by the National Cancer Institute with study goals of enrolling WHI participants who have been diagnosed with cancer into a cancer survivorship cohort and then examining factors that may affect life and longevity among women who have been diagnosed with cancer.
WHIMS was an ancillary study to the WHI Hormone Trials and enrolled 7,427 women aged 65 years and older. WHIMS investigated the effects of hormone supplementation on risk of probable dementia and any cognitive impairment and on changes in global cognition over time.
The OPACH study was an ancillary study of the WHI Long Life Study. Long Life Study participants who were ambulatory were concurrently invited to join the OPACH study. The goal of OPACH was to increase the understanding of the health benefits and risks of physical activity, specifically with cardiovascular events and incident falls.
The WHISPER study examines whether sleep-disordered breathing and the resulting low blood oxygen are associated with increased risks of health events, including heart attack, stroke, heart failure, cancer, and cognitive decline.
|Id||Name||PI Name||Status||Funding Agency||Grant Number||Datafiles|
|689||Helicobacter infection and liver cancer risk among African Americans and Whites in the United States||Zhang, Xuehong||Approved||N|
|688||The role of the social environment in the association between air pollution and cardiovascular disease||Hajat, Anjum||Approved||N|
|687||Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts||Desai, Pinkal||Approved||N|
|685||Genome-wide enrichment of functionally important alleles and association studies of metabolic traits in Pacific Island populations||Chiang, Charleston||Approved||N|
|682||Methylmercury exposure and risk of renal cell carcinoma||Luo, Juhua||Approved||N|
|679||Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States||Zhang, Xuehong||Approved||N|
|674||Endocrine disrupting chemicals and postmenopausal breast cancer risk||Reeves, Katherine||Approved||N|
|673||DNA methylation as a novel epigenetic biomarker that regulates metabolic and inflammatory cytokines in the development of obesity-attributable cancers||Jung, Su Yon||Approved||N|
|671||Infection-based markers of glioma risk in the NCI Cohort Consortium||Egan, Kathleen||Approved||N|